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 Oxidative stress can be viewed as an imbalance between
the production and clearance of reactive oxygen species (ROS)
[1]. Although the mechanism that produces ROS may differ
in different conditions, an influx of Ca2+ is probably linked
with cell damage during oxidative stress [2,3]. Retina and reti-
nal neurons, with their relatively high oxygen consumption
and constant exposure to light, are prone to oxidative stress
[4,5]. Oxidative stress also may be related to the pathogenesis
of glaucomatous optic neuropathy (GON) [1,6]. Thus, oxida-
tive stress is an important factor that is studied both clinically
and in the laboratory and can be correlated with both retinal
disease and GON. In vivo and in vitro studies demonstrated
that oxidative stress-induced retinal ganglion cell (RGC) death
could be alleviated by down-regulation of the downstream sig-
naling protein, apoptosis signal-regulating kinase 1, or by ad-
dition of anti-oxidants, such as flavonoids or cannabinoids [7-
9].
β-adrenergic antagonists (β-blockers) have been widely
used as intra-ocular pressure (IOP)-lowering agents for the
treatment of glaucoma,, and there are many reports in the lit-
erature about their in vitro neuroprotective effects. For ex-
ample, timolol, a non-selective β-blocker, reportedly allevi-
ated retinal neuronal damage induced by ischemia in animal
models [10]. In addition, timolol protected RGCs against dam-
age induced by anoxia in mixed retinal cell cultures [11], and
from damage caused by glutamate in purified cultured RGCs
[12]. Betaxolol, a selective β-blocker, was reported to show
protective effects on retinal cells including RGCs from is-
chemic and N-methyl-D-aspartate (NMDA)-induced insults
in animal models [10,13], and protect retinal neurons from a
glutamate insult in mixed retinal cell cultures [14]. Carteolol,
a non-selective β-blocker, inhibited Ca2+ influx in neuronal
cells at high concentrations [15,16]. Furthermore, it showed a
cytoprotective effect on UV-induced corneal epithelial cell
death [17]. Nipradilol, a non-selective β- and selective β1-
blocker with nitric oxide (NO) releasing activity [18], has been
reported to protect the retina from NMDA-induced or is-
chemia-reperfusion conditioned insult in animal models
[19,20]. It also enhanced viability of cells in purified RGC
cultures [21]. The effects of these β-blockers on oxidative
stress-induced RGC damage, however, have not been studied.
Oxidative stress can be induced in cell culture by either
adding oxidative agents, by using medium without anti-oxi-
dants [21-23], or by depriving cells of serum [24]. Some in-
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Purpose: To investigate the effect of β-adrenergic receptor antagonists against oxidative stress on purified rat retinal
ganglion cells (RGCs), timolol, betaxolol, carteolol and nipradilol were included in the present study.
Methods: RGCs were purified using a 2 step panning procedure from postnatal days 6-8 using Wistar rats. After 72 h in
culture under normal condition, RGCs were exposed to oxidative stress induced by B27 medium without anti-oxidant. To
verify whether this stress is apoptotic or necrotic, Annexin V and propidium iodide were used to detect apoptotic and
necrotic cells after 2 h stress. The presence of a proinhibitor for intracellular cathepsin B, and an inhibitor for thiol
protease (cathepsin B/H/L, calpain), was also assessed to verify necrotic cell death event in oxidative conditions. Next,
RGC cultures under oxidative stress were incubated with timolol, betaxolol, carteolol, and nipradilol added, respectively,
for 24 h culture. The RGC viability in each condition normalized to that under normal condition was evaluated as live cell
percentage based on total experiments of 8-15.
Results: Two h after oxidative stress, Annexin V and propidium iodide positive cells increased. Increased cell death under
oxidative stress was significantly reduced by inhibitors for cathepsin or calpain. These data suggest that increased cell
death under the current oxidative stress was due to necrosis. Under oxidative stress for 24 h, RGC viability reduced to
52.5-60.2% as compared with normal. With 10 nM and 100 nM timolol, live cell significantly increased to 69.3% and
75.5%, respectively. Both betaxolol and nipradilol enhanced live RGCs significantly in concentration of 100 nM and 1
µM, with viability of 70.5%, 71.6%, and 70.4%, 74.7%, respectively. While with 10 nM, 100 nM and 1 µM addition of
carteolol, there was no significant increase in live RGC percentage which ranged from 53.1-55.0%.
Conclusions: Timolol, betaxolol and nipradilol, but not carteolol, showed neuroprotective effects against oxidative stress
induced by B27 without antioxidant on purified rat RGCs at concentrations of 10 nM or higher. Although the neuroprotective
mechanism of β-blockers for oxidative stress is still unknown, this additive effect may deserve future studies.
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833vestigators have used mixed retinal cell cultures to assess the
neuroprotective effects of drugs against various kinds of dam-
age to RGCs [10,14]. However, it is difficult to exclude the
latent mutual influence of other retinal cells on RGCs by this
method [25]. On the other hand, purified cultured RGCs pro-
vide a simpler way to examine the effect of an agent on RGCs
themselves, excluding confounding influences from other reti-
nal cells.
In the present study, we investigated the effects of timolol,
betaxolol, carteolol, and nipradilol on oxidative stress induced
by excluding anti-oxidants from the neuronal culture medium
on purified cultured rat RGCs. Rather unexpectedly, we found
that some of the tested β-blockers showed protective effects
against oxidative stress in RGCs at concentrations as low as
10 nM.
METHODS
Materials:  The animals used in this study were treated in ac-
cordance with the ARVO Statement for the Use of Animals in
Ophthalmic and Vision Research. Poly-L-Lysine, bovine se-
rum albumin (BSA), L-glutamine, and human recombinant
brain-derived neurotrophic factor (BDNF) and rat recombi-
nant ciliary neurotrophic factor (CNTF) were obtained from
Sigma (St. Louis, MO). The papain dissociation system was
from Worthington Biochemical (Lakewood, NJ); mouse anti-
rat SIRP [CD172a] monoclonal antibody (MAB 1407P) and
mouse anti-rat and mouse Thy1.1 monoclonal antibody
(MAB1406) were obtained from Chemicon International
(Temecula, CA) Vybrant® apoptosis assay kit and Live/Dead
viability cytotoxicity kit (L-3224) were obtained from Mo-
lecular Probes (Eugene, OR). Timolol maleate was obtained
from Merck & Co., Inc (Rahway, NJ), betaxolol was from
Alcon Inc.(Fortworth, TX), carteolol was from Otsuka Phar-
maceutical (Tokyo, Japan) and nipradilol was from Kowa Ltd.
(Tokyo, Japan). CA-074 Me, a proinhibitor for intracellular
cathepsin B, and E-64-d, an inhibitor for thiol proteases (cathe-
psin B/H/L, calpain), were purchased from Peptide Institute,
Inc. (Osaka, Japan). Other reagents were obtained from
Invitrogen (Carlsbad, CA) unless noted. B-27 supplement
minus anti-oxidants (AO-) was purchased from Gibco (Grand
Island, NY).
Purified rat retinal ganglion cell culture:  RGC cultures
were obtained from the retinas of 6- to 8-day-old Wistar rats,
following the two step immuno-panning procedure [26,27].
Briefly, retinas were dissociated into cell suspensions using
the papain dissociation system. Separately, 50 ml flasks and
50 ml tubes were incubated with anti-rat macrophage anti-
body (1:50 dilution) and anti-rat and mouse Thy1.1 antibody
(1:300 dilution) in phosphate buffered saline (PBS), respec-
tively, at 4 °C overnight. Antibodies were removed and the
cell suspension was incubated in the anti-macrophage anti-
body coated flask for 1 h. Suspensions containing cells that
did not adhere to this flask were transferred to tubes coated
with Thy1.1 antibody for 1 h. Cells adhering to the tube (RGCs)
were resuspended in serum-free neurobasal medium (Gibco)
supplemented with 2% B27 supplement, BDNF (40 ng/ml),
CNTF (40 ng/ml) and forskolin (10 µM) and seeded onto 13
mm coverslips, placed within 24-well plates. The coverslips
had been autoclaved, coated with 0.05 mg/ml of poly-L-lysine
(Sigma) overnight, rinsed twice with Hanks’ buffered saline
solution (HBSS) and then coated for 2 h with 1 µg/ml of
laminin (Gibco). RGCs were cultured for 3 days under
normoxic conditions (20% O2, 5% CO2, 37 °C) before each
experiment in serum-free B27 complete medium containing
neurobasal medium (Gibco) with 1 mM L-glutamine (Sigma),
B27 supplement (Gibco), 40 ng/ml BDNF, 40 ng/ml rat CNTF,
10 µM forskolin. In order to acquire fully-isolated RGCs, the
density of RGCs in each well was seeded at approximately
500 cells/cm2 [26,27].
Oxidative stress:  After 3 days of cultivation, control cov-
erslips were moved to freshly prepared neurobasal medium
with B27 supplement (AO+), while coverslips for oxidative
treatment were moved to neurobasal medium containing B27
but without anti-oxidants (AO-). Regular B27 supplement
contains potent antioxidants (reduced glutathione, vitamin E,
vitamin E acetate, catalase and superoxide dismutase) but B27
without antioxidants (AO-) does not contain these 5 com-
pounds [28]. This AO- medium was used to induce RGC dam-
age by oxidative stress [23].
Detection of necrotic and apoptotic cells:  RGCs were
incubated under AO+ or AO- for 2 h and then Alexa Fluor
488-conjugated annexin V binding, combined with propidium
iodide labeling, was performed [29,30]. Apoptotic RGCs were
stained as annexin V positive and propidium iodide negative
(annexin V+/propidium iodide-), and necrotic ones were posi-
tively stained with both annexin V and propidium iodide
(annexin V+/propidium iodide+). Undamaged RGCs remained
negative for both stains [29,30]. At the end of the above double
staining, Hoechst 33342 was added to the culture medium at 8
µM. Cells were counted in at least 10 random fields of each
well at 200X magnification using a fluorescence microscope
(Nikon Eclipse TE300, Tokyo, Japan). The percentages of
apoptotic and necrotic RGCs were quantified by determining
the ratio of annexin V+/propidium iodide- cells, and annexin
V+/propidium iodide+ cells, to Hoechst 33342-positive RGCs.
Additionally, RGCs cultured in AO+ conditions with the ad-
dition of staurosporine (final concentration, 30 µM) were si-
multaneously assessed as a positive control for apoptosis and
necrosis [31]. RGCs cultured in AO- conditions with the ad-
dition of CA-074 Me, a proinhibitor for intracellular cathep-
sin B, or E-64-d, an inhibitor for thiol protease (cathepsin B/
H/L, calpain; final concentration, 50 µM) were also simulta-
neously assessed.
Application of β-blockers:  For evaluating the effects of
timolol, betaxolol, carteolol and nipradilol on the oxidative
stress-induced damage of RGCs, cells were incubated in AO-
medium with or without β-blockers for 24 h after 72 h incuba-
tion in AO+ medium. We preliminarily examined the effect of
each blocker at 10 nM and compared to the control AO- con-
dition. As a result, timolol was only effective among 4 blockers
at 10 nM. Finally, considering the limited samples of primary
culture of RGCs, 3 concentrations, 1, 10, and 100 nM for
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834timolol and 10, 100, and 1000 nM for other 3 β-blockers, were
applied to RGC culture for further 24 h.
Assay of RGC survival rate:  Following 24 h in the pres-
ence of β-blockers, RGCs were processed for viability by la-
beling with calcein-AM (2 µM), a component of the Live/
Dead Viability/Cytotoxicity kit as documented previously [26].
Ethidium homodimer-1 (2.5 µM) labeling was used to observe
dead cells. In the present study, live RGCs were defined as
having a calcein-stained cell body with neurites extending at
least 2 cell diameters from the cellular body. RGC viability in
AO- group with or without β-blockers was calculated from 2
wells, normalized to control AO+ group cultivated in parallel
under the same conditions, and indicated as RGC survival rate.
The average cell survival percentage of 8 experiments for each
condition was expressed in the text and figures as the
mean±standard deviation (SD).
Statistical analyses:  One way ANOVA analysis followed
by the Tukey test and Dunnett test were used in this study. All
data are indicated as mean±SD.
RESULTS
Oxidative stress:  The effects of AO+ and AO- culture me-
dium were assessed on RGCs in culture. The appearance of
rat RGCs cultured under AO+ conditions is shown in Figure
1A-C. RGCs undergoing 3 days of AO+ culture and then trans-
ferred to AO- culture medium are shown in Figure 1D-F. Un-
der oxidative stress for 24 h, the number of live RGCs de-
creased, the dendrites were shortened and their contours de-
formed.
Detection of necrotic and apoptotic cells:  The percent-
age of necrotic and apoptotic cells was evaluated for each con-
dition (Figure 2). After 2 h incubation, the apoptotic RGCs
percentages were 17.0±7.7% in the control AO+ group,
22.3±3.6% in the AO- group, 22.0±4.9% in the E-64-d group,
26.6±5.5% in the Ca-074 Me group, and 40.1±7.1% in the
staurosporine-treated group. There was no significant differ-
ence between the AO+ group and the AO- group, while the
apoptotic cell percentage in the staurosporine-treated group
was significantly higher than all the other groups (p<0.05 by
©2007 Molecular Vision Molecular Vision 2007; 13:833-9 <http://www.molvis.org/molvis/v13/a91/>
Figure 1. Rat retinal ganglion cell death by oxidative stress.  Rat retinal ganglion cells (RGCs) after 72+24 h of culture under AO+ conditions
(A, B, C) or AO- conditions (D, E, F). A, D: Phase contrast images of RGCs without labeling. B, E: Live cells with labeling of calcein-AM.
C, F: Dead cells (red) with labeling of both calcein-AM and ethidium homodimer-1. The dendrites become shortened and cellular bodies had
a deformed appearance (arrows). The scale bar represents 50 µm.
835Tukey test). Both the cathepsin B proinhibitor (E-64-d) and
thiol protease inhibitor (Ca-074 Me) added to AO- medium
had no effect on apoptotic cell death. For necrotic RGCs, the
percentages for the AO+, AO-, E-64-d, Ca-074 Me, and
staurosporine-treated groups were 14.3±4.9%, 49.6±7.6%,
22.5±4.7%, 21.8±3.9%, and 36.3±13.1%, respectively. The
percentage of necrotic cells in the AO- and staurosporine-
treated groups were significantly higher than that of the AO+
control cells (p<0.05 by Tukey test). Necrotic RGCs percent-
ages in the E-64-d and Ca-074 Me groups were significantly
lower than that of the AO- group (p<0.05), but there was no
significant difference from the AO+ group. These results in-
dicated that AO- conditions increased necrotic cell death, but
not apoptotic cell death.
Effect of timolol:  The effect of the non-selective β-blocker,
timolol, on oxidative stress-induced RGC damage was inves-
tigated (Figure 3). In the control AO- group, RGC viability
was 58.3 ±5.6%, while with 1 nM, 10 nM, and 100 nM timolol
added it was 62.5±6.2%, 68.4 ±6.8%, and 75.2±6.5%, respec-
tively (n=8). At 10 and 100 nM, timolol significantly increased
RGC viability (Dunnet test, p<0.01-0.05).
Effect of betaxolol:  The effects of betaxolol on oxidative
stress-induced RGC damage are summarized in Figure 4. Vi-
ability of RGCs without betaxolol and with 10 nM betaxolol
was 59.8±4.8% and 63.2±8.8%, respectively. Betaxolol, 100
nM and 1 µM, significantly increased RGC viability to
69.2±8.6% and 71.0±7.2%, respectively. (Dunnet test, p<0.01-
0.05).
Effect of carteolol:  Carteolol showed no significant ef-
fect on oxidative stress-induced damage of RGCs by Dunnet
test (Figure 5). The viability of RGCs in AO- conditions, with
the addition of 0, 10 nM, 100 nM, and 1 µM carteolol, was
52.5±9.9%, 53.2±15.3%, 55.0±14.4%, and 53.1±18.5%, re-
spectively.
Effect of nipradilol:  The effect of nipradilol on oxidative
stress-induced RGC damage was investigated (Figure 6). At
100 nM and 1 µM, nipradilol significantly increased RGC vi-
ability to 69.3±7.2% and 73.7±7.1%, respectively, while it was
57.8±6.2% and 63.0±7.2% without nipradilol and with 10 nM
nipradilol, respectively. (Dunnet test, p<0.01-0.05).
DISCUSSION
 In the present study, B27 supplement without the anti-oxi-
dants glutathione, vitamin E, vitamin E acetate, catalase, and
superoxide dismutase, was used as an oxidative insult. The
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Figure 2. Detection of apoptotic and necrotic retinal ganglion cells
under oxidative stress.  Apoptotic retinal ganglion cells (RGCs) were
significantly increased in the staurosporine-treated RGCs, but not in
any other condition. Necrotic RGCs were significantly increased in
the AO- and staurosporine conditions. E64-d and Ca-074 Me signifi-
cantly reduced the necrotic cell percentage compared to the AO- con-
ditions, but the values were not significantly different from the AO+
group. Each value represents mean±SD, (n=8). Asterisk indicates
p<0.05, versus all the other groups (Tukey test).
Figure 3. Effect of timolol on oxidative stress-induced retinal gan-
glion cell damage.  Following 24 h under AO- condition in the pres-
ence of timolol, the survival rate of RGC was assessed and normal-
ized to that of the control AO+ condition. At 10 and 100 nM, timolol
significantly increased retinal ganglion cell viability. Data are ex-
pressed as mean±SD, n=8. Asterisk indicates p<0.05; cross symbol
indicates p<0.01 by Dunnet test.
Figure 4. Effect of betaxolol on oxidative stress-induced retinal gan-
glion cell damage.  Following 24 h under AO- condition in the pres-
ence of betaxolol, the survival rate of RGC was assessed and nor-
malized to that of the control AO+ condition. At 100 nM and 1 µM,
betaxolol significantly increased RGC viability. Data are expressed
as mean±SD, n=8. Asterisk indicates p<0.05 by Dunnet test.
836relative contributions of necrotic and apoptotic cell death de-
pend on several factors, including the energy content of the
cell and the severity of the insult [32]. Contrary to apoptosis,
necrosis is not programmed cell death but occurs when cells
are exposed to extreme stress [33]. For example, high concen-
trations of peroxynitrite induce necrosis in cortical neuron
cultures, while at low concentrations it induced apoptosis [34].
Moreover, intracellular signaling pathways activated by vari-
ous oxidative stresses are complicated, and there may be cross-
talk between different pathways that, results in cell death. In
the retinal ganglion cell line RGC-5, H2O2- or tert-butyl per-
oxide-induced cell death did not involve the classic apoptotic
pathway, but caused glutathione depletion, which in turn gen-
erated a high concentration of glutamate, that induced DNA
fragmentation as ROS did not scavenged [35]. These reports
indicate that necrosis and apoptosis may be induced simulta-
neously and often are not easily distinguished. Detection of
the type of cell death in our oxidative stress model showed
that necrotic cell death was predominantly induced in AO-
conditions. This was inhibited by the protease inhibitors of
necrotic cell death, calpain or cathepsin. The current results
suggest that depleting anti-oxidants might provide a stronger
insult than other oxidative stress models and that B27 without
anti-oxidant could be useful for investigating the mechanism
of necrotic cell death with and without prior treatment with
drugs. In this oxidative stress model, timolol showed a sig-
nificant dose-dependent protective effect at a concentration
on 10 nM and higher, while betaxolol and nipradilol also were
found to be protective at 100 nM and higher.
Little is known about the molecular mechanisms required
to induce necrotic cell death. Proteolysis is thought to play an
important role in necrosis, and caspases, calpain, and cathep-
sins are mainly involved in necrotic cell death and
neurodegeneration [33]. All these proteases can be activated
directly or indirectly by an excessive increase of intracellular
calcium. In fact, it was also reported that an increase of intra-
cellular Ca2+ was associated with oxidative damage to cells
[2,3]. Furthermore, oxidative stress may cause a Na+ influx
concurrently, through L-type voltage-sensitive Ca2+ channels
[36]. Thus, it is possible that the protective effect of some β-
blockers may be explained based on the calcium induced pro-
teolytic signals initiated by oxidative stress.
The neuroprotective effects of timolol and betaxolol on
glutamate-, anoxia- or ischemia-induced insults have been
reportedly attributed to their inhibition of Ca2+ and/or Na+ in-
flux [10-12,14,37-40]. Nipradilol may also be able to reduce
the influx of Ca2+ into the neuron through an α-1 adrenoceptor
antagonistic effect [41]. However, according to previous stud-
ies, the IC50 for these effects was 1 µM or higher [12,41,42].
Since timolol was effective at 10 nM and betaxolol and
nipradilol at 100 nM, the protective effects against oxidative
stress-induced RGC damage encountered in this study are dif-
ficult to be attributed to Ca2+ and/or Na+ influx. β-blocking
alone is also unlikely to be related since carteolol showed no
effect.
Although the exact mechanism is unclear, the current study
shows that betaxolol, timolol, and nipradilol could dose-de-
pendently improve the survival rate of cultured purified RGCs
under oxidative stress, at concentrations of 10 nM or 100 nM.
Several previous studies showed that betaxolol, timolol, or
nipradilol penetrates normal rabbits’ ipsilateral retina at 100
nM when these agents were topically applied [12,13,20]. It
must be noted however that direct extrapolation of results ob-
tained in rabbits to humans is difficult. Recently, Grover et al
reported that one of topical IOP-lowering drugs inhibiting
carbonic anhydrase, dorzolamide, caused a significant decrease
in retinal thickness in retinitis pigmentosa complicated with
cystoid macular edema in humans [43]. Since the concentra-
tion of dorzolamide in plasma should not be high enough to
cause any pharmacological effects attributable to inhibition
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Figure 5. Effect of carteolol on oxidative stress-induced retinal gan-
glion cell damage.  Following 24 h under AO- condition in the pres-
ence of carteolol, the survival rate of RGC was assessed and normal-
ized to that of the control AO+ condition. Carteolol showed no sig-
nificant effect on oxidative stress-induced damage of RGCs. Data
are expressed as mean±SD, n=8.
Figure 6. Effect of nipradilol on oxidative stress-induced retinal gan-
glion cell damage.  Following 24 h under AO- condition in the pres-
ence of nipradilol, the survival rate of RGCs was assessed and nor-
malized to that of the control AO+ condition. Nipradilol (100 nM
and 1 µM) significantly increased RGC viability. Data are expressed
as mean±SD, n=8. Asterisk (*) indicates p<0.05; christ symbol indi-
cates p<0.01 by Dunnet test.
837of carbonic anhydrase [44], this effect may be attributable to
dorzolamide locally penetrating the posterior fundus after in-
stillation. Therefore, in addition to their IOP-lowering effects,
some β-blockers directly alleviate oxidative stress-induced
RGC damage in vivo.
In conclusion, oxidative stress induced RGC death were
alleviated by some of beta-blockers. Retina and retinal neu-
rons are susceptible to oxidative stress because these tissues
consume high oxygen and exposed to light, and oxidative stress
are related to GON [1,4-6]. Thus, β-blockers are expected to
have neuroprotective effect in addition to IOP reduction. Al-
though the neuroprotective mechanism of β-blockers for oxi-
dative stress is still unknown, this additive effect may deserve
future studies.
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